Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses
Viral Immunology · 2023
DOI: 10.1089/vim.2023.0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viral Immunology, 2023. Verfasst von Somayeh Kalanaky und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran. Hauptthemen laut MEDLINE: Cytokines, COVID-19. Die Arbeit nennt 64 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Research and Development, Sodour Ahrar Shargh Company, Tehran, Iran.
- Chronic Respiratory Diseases Research Center, NRITLD, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of BCG Vaccine Production, Production and Research Complex, Pasteur Institute of Iran, Karaj, Iran.
- Department of FMD Vaccine Production, Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization (AREEO), Karaj, Iran.
- Advanced Therapy Medicinal Product (ATMP) Department, Breast Cancer Research Center, Motamed Cancer Institute, Academic Center for Education, Culture and Research (ACECR), Tehran, Iran.
- Recombinant Vaccine Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Akbar Khorasani, Mehdi Mahdavi, Mohammad Hassan Nazaran
Zitieren
APA
Kalanaky, S., Fakharzadeh, S., Karimi, P., Hafizi, M., Jamaati, H., Hassanzadeh, S. M., Khorasani, A., Mahdavi, M., & Nazaran, M. H. (2023). Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses. Viral Immunology. https://doi.org/10.1089/vim.2023.0001
Vancouver
Kalanaky S, Fakharzadeh S, Karimi P, Hafizi M, Jamaati H, Hassanzadeh SM, et al. Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses. Viral Immunology. 2023. doi:10.1089/vim.2023.0001
BibTeX
@article{Kalanaky2023,
author = {Kalanaky, Somayeh and Fakharzadeh, Saideh and Karimi, Pegah and Hafizi, Maryam and Jamaati, Hamidreza and Hassanzadeh, Seyed Mehdi and Khorasani, Akbar and Mahdavi, Mehdi and Nazaran, Mohammad Hassan},
title = {Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses},
journal = {Viral Immunology},
year = {2023},
doi = {10.1089/vim.2023.0001}
}
EUVIMED